FENOCOR 35

Main information

  • Trade name:
  • FENOCOR 35 10 TAB
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FENOCOR 35 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

11-12-2017

FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

Today, the U.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores – retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements. The “Every Try Counts” campaign targets smokers ages 25-54 who have attempted to quit ...

FDA - U.S. Food and Drug Administration

3-7-2014

More clinical trials to Denmark

More clinical trials to Denmark

The number of clinical trial applications increased by 35 trials (14%) from 2012 to 2013, which is the highest level in seven years. The increase covers both companies and researchers according to the Danish Health and Medicines Authority's annual report 2013 on clinical trials of medicines in humans.

Danish Medicines Agency

28-5-2014

More than 10,000 websites shut down in global operation

More than 10,000 websites shut down in global operation

The recent global Operation PANGEA VII resulted in the shutdown of more than 10,000 websites. The operation focused on combating online sale of counterfeit medicines and making consumers aware that they need to take care of themselves when buying medicines online. Globally, the operation led to 237 arrests, some 540,000 parcels were inspected and over 9.4 million units containing potentially life-threatening medicines were seized – worth an estimated value of more than USD 35 million. More than 10,000 we...

Danish Medicines Agency

10-4-2018

T-35 (Aesculus Hippocastanum Whole) Solution [DNA Labs, Inc.]

T-35 (Aesculus Hippocastanum Whole) Solution [DNA Labs, Inc.]

Updated Date: Apr 10, 2018 EST

US - DailyMed

28-3-2018

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (Active substance: Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide) - Transfer of orphan designation - Commission Decision (2018)2011 of Wed, 28 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/17/T/01

Europe -DG Health and Food Safety

12-2-2018

BADGER SPORT SPF 35 SUNSCREEN (Zinc Oxide) Cream [W.S. Badger Company, Inc.]

BADGER SPORT SPF 35 SUNSCREEN (Zinc Oxide) Cream [W.S. Badger Company, Inc.]

Updated Date: Feb 12, 2018 EST

US - DailyMed

23-1-2018

News and press releases:  Human medicines: highlights of 2017

News and press releases: Human medicines: highlights of 2017

92 medicines recommended for approval, including 35 with a new active substance

Europe - EMA - European Medicines Agency

28-12-2017

CYCLAFEM 1/35 (Norethindrone And Ethinyl Estradiol) Kit [Par Pharmaceutical]

CYCLAFEM 1/35 (Norethindrone And Ethinyl Estradiol) Kit [Par Pharmaceutical]

Updated Date: Dec 28, 2017 EST

US - DailyMed

20-12-2017

Regulatory and procedural guideline:  Questions and answers on Article 35 veterinary referral procedures

Regulatory and procedural guideline: Questions and answers on Article 35 veterinary referral procedures

This guidance document addresses a number of questions which stakeholders, in particular the applicants or marketing authorisation holders (MAHs), may have on Article 35 referral procedures to the Committee for Medicinal Products for Veterinary Use (CVMP). It provides an overview of the European Medicines Agency’s (‘the Agency’) practical and operational aspects with regards to the handling of Article 35 referral procedures.

Europe - EMA - European Medicines Agency

19-12-2017

NU-DERM HEALTHY SKIN PROTECTION SPF 35 (Octinoxate And Zinc Oxide) Cream [OMP, Inc.]

NU-DERM HEALTHY SKIN PROTECTION SPF 35 (Octinoxate And Zinc Oxide) Cream [OMP, Inc.]

Updated Date: Dec 19, 2017 EST

US - DailyMed

30-11-2017

Most US Children Today Will Be Obese by Age 35

Most US Children Today Will Be Obese by Age 35

Over half of today's children in the United States will be obese at the age of 35 if existing trends continue, despite the fact that currently, less than 20% of them are obese, a new simulated growth trajectory model indicates.

US - RxList

30-11-2017

60 Percent of U.S. Kids Could Be Obese by Age 35

60 Percent of U.S. Kids Could Be Obese by Age 35

Title: 60 Percent of U.S. Kids Could Be Obese by Age 35Category: Health NewsCreated: 11/29/2017 12:00:00 AMLast Editorial Review: 11/30/2017 12:00:00 AM

US - MedicineNet

21-11-2017

MI Linked to Increased Vascular Dementia, Not Alzheimer's

MI Linked to Increased Vascular Dementia, Not Alzheimer's

A history of MI is associated with an increased risk of vascular dementia by as much as 35%, with the higher risk extending as far as 35 years after the event, results of a population-based study suggest[1].

US - RxList

15-11-2017

ACMD meeting statement, Meeting 35, 24 August 2017

ACMD meeting statement, Meeting 35, 24 August 2017

ACMD 35 meeting statement has been published

Therapeutic Goods Administration - Australia

29-9-2017

Zanil and associated names, and generic products thereof

Zanil and associated names, and generic products thereof

Zanil and associated names, and generic products thereof (Active substance: Oxyclozanide) - Community Referrals - Art 35 - Commission Decision (2017)6711 of Fri, 29 Sep 2017 European Medicines Agency (EMA) procedure number: EMEA/V/A/124

Europe -DG Health and Food Safety

29-8-2017

BRIGHT FUTURE SKIN TINT SPF 25 35 BRONZE (Octinoxate, Titanium Dioxide) Cream [S+]

BRIGHT FUTURE SKIN TINT SPF 25 35 BRONZE (Octinoxate, Titanium Dioxide) Cream [S+]

Updated Date: Aug 29, 2017 EST

US - DailyMed

11-7-2017

veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp.

veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp.

veterinary medicinal products containing tylosin that are administered parenterally and intended for the treatment of bovine mastitis caused by Mycoplasma spp. (Active substance: Not available) - Community Referrals - Art 35 - Commission Decision (2017) 4997 of Tue, 11 Jul 2017 European Medicines Agency (EMA) procedure number: EMEA/V/A/121

Europe -DG Health and Food Safety

27-6-2017

Zinc oxide - Veterinary medicinal products containing zinc oxide to be administered orally to food producing species

Zinc oxide - Veterinary medicinal products containing zinc oxide to be administered orally to food producing species

Zinc oxide - Veterinary medicinal products containing zinc oxide to be administered orally to food producing species (Active substance: zinc oxide) - Community Referrals - Art 35 - Commission Decision (2017)4529 of Tue, 27 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/V/A/118

Europe -DG Health and Food Safety

27-6-2017

Recall: Britax B-Safe 35 Car Seat Chest Clip

Recall: Britax B-Safe 35 Car Seat Chest Clip

Title: Recall: Britax B-Safe 35 Car Seat Chest ClipCategory: Health NewsCreated: 6/24/2017 12:00:00 AMLast Editorial Review: 6/26/2017 12:00:00 AM

US - MedicineNet

21-6-2017

Veterinary medicinal products containing methylprednisolone hydrogen succinate presented as solutions for injection for use in target species cattle

Veterinary medicinal products containing methylprednisolone hydrogen succinate presented as solutions for injection for use in target species cattle

Veterinary medicinal products containing methylprednisolone hydrogen succinate presented as solutions for injection for use in target species cattle (Active substance: Methylprednisolone hydrogen succinate) - Community Referrals - Art 35 - Commission Decision (2017)4364 of Wed, 21 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/V/A/119

Europe -DG Health and Food Safety

19-6-2017

Clopidogrel Mylan (Mylan S.A.S)

Clopidogrel Mylan (Mylan S.A.S)

Clopidogrel Mylan (Active substance: Clopidogrel) - Centralised - 2-Monthly update - Commission Decision (2017)4265 of Mon, 19 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/1134/IB/35/G

Europe -DG Health and Food Safety

6-6-2017

Metabolic Syndrome Quiz: Test Your Medical IQ

Metabolic Syndrome Quiz: Test Your Medical IQ

Title: Metabolic Syndrome Quiz: Test Your Medical IQCategory: MedicineNet QuizCreated: 10/26/2012 3:41:00 PMLast Editorial Review: 6/6/2017 1:35:50 PM

US - MedicineNet

23-5-2017

EU/3/17/1876 (TMC Pharma Services Ltd)

EU/3/17/1876 (TMC Pharma Services Ltd)

EU/3/17/1876 (Active substance: Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide) - Orphan designation - Commission Decision (2017)3609 of Tue, 23 May 2017 European Medicines Agency (EMA) procedure number: EMA/OD/010/17

Europe -DG Health and Food Safety

18-5-2017

Nevanac (Novartis Europharm Limited)

Nevanac (Novartis Europharm Limited)

Nevanac (Active substance: nepafenac) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2017)3446 of Thu, 18 May 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/818/T/35

Europe -DG Health and Food Safety

16-5-2017

#Recall: ReFlow Wingman 35 Crossing Catheters due to Tip Separation  https://go.usa.gov/xNTFJ  #fda #medicaldevice

#Recall: ReFlow Wingman 35 Crossing Catheters due to Tip Separation https://go.usa.gov/xNTFJ  #fda #medicaldevice

#Recall: ReFlow Wingman 35 Crossing Catheters due to Tip Separation https://go.usa.gov/xNTFJ  #fda #medicaldevice

FDA - U.S. Food and Drug Administration